News and Media

We're just getting started. Amazing possibilities lie ahead.

The Institute for Applied Cancer Science, officially launched on Nov. 28, 2011, enhances and complements many other programs at MD Anderson, spanning basic, translational and clinical research. It also serves to foster collaborative interactions with pharmaceutical industry research and development groups.

Explore press releases about the Institute and our achievements:

Agilent Technologies Thought Leader Award Supports Dr. Ronald A. DePinho and Translational Research Program at MD Anderson Cancer Center

UT MD Anderson and GlaxoSmithKline to collaborate on new approach to cancer immune therapy; success could earn cancer center $335 million plus royalties

Belfer gift creates consortium targeting neurodegenerative diseases

Institute of Medicine Elects Lynda Chin to Membership

Institute to Enable Drug Discovery and Development Platform of Unprecedented Moon Shots Program

Drug combination against NRAS-mutant melanoma discovered

Institute Brings New Hope for Better Cancer Drugs

New Institute to Accelerate Cancer Drug Development

Learn more about the Institute

Giulio Draetta Discusses the Advantages of the Institute's Approach

Lynda Chin Discusses the Work of the Institute

Institute Leaders Discuss Mission and Goals

Announcement of the Institute for Applied Cancer Science

March 2013
December 2012

MD Anderson Hightlights

Conquest: IACS Infographic

Cancer Frontline: Institute of Medicine Elects Lynda Chin to Membership

Promise: Academia Meets Biotech in New Institute

Promise: Ronald DePinho Announces IACS

Conquest: Academic Insight, Industrial Execution

Cancerwise: Institute to Bring New Hope for Better Cancer Drugs

External Media Coverage

IACS Established

Governor’s press release
KUT
Houston Chronicle
Boston Globe

GSK Collaboration Announced

FierceBiotech
Drug Discovery News
Houston Business Journal
KUHF Radio Interview
BioWorld

Moon Shot Program Launched

Time Magazine: Cancer Dream Teams
Time Magazine: The Conspiracy To End Cancer

NDC Established

Houston Chronicle
Drug Discovery News
Houston Business Journal

Join our Team

Find your place on our dynamic team.

Contact Us

Institute for Applied Cancer Science
MD Anderson Cancer Center
1901 East Road
Houston TX 77054
Tel: 713-745-2600

For questions concerning collaborations or partnerships, please contact:

Eric Devroe
Executive Director of Strategic Alliances
EJDevroe@mdanderson.org

We need your help

Philanthropic support will provide IACS several critical advantages that will ultimately benefit cancer patients by providing them with novel treatments in a shorter timeframe. If you’re interested in advancing this transformative venture, please donate through the myGiving site.